FDA Adverse Event Injury Summary report: N

VENTAK PRIZM

MDR report key: 1863595 · Received October 11, 2010

Report

Report Number
2124215-2010-15398
Event Type
Injury
Date Received
October 11, 2010
Date of Event
August 3, 2010
Report Date
September 16, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON ANALYSIS, THIS EVENT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

ADDITIONAL TESTING REVEALED THAT THIS DEVICE FAILED THE INDUCED SHOCK (DELIVERED ENERGY) TEST. THE DEVICE WAS STABILIZED AND AN INDUCED SHOCK WAS PERFORMED, WHICH RESULTED IN THE DEVICE DELIVERING A 30.34 JOULE SHOCK. THIS WAS OUT OF SPECIFICATION FOR THIS DEVICE.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THIS DEVICE WAS AT ELECTIVE REPLACEMENT INDICATOR (ERI). LONGEVITY CALCULATIONS DETERMINED THAT THIS DEVICE DID NOT MEET THE EXPECTED LONGEVITY BASED ON PROGRAMMED PARAMETERS AND THERAPY HISTORY. THE VENTAK PRIZM VR HE ERI CAN BE TRIPPED EITHER BY VOLTAGE OR CHARGE TIME. ANALYSIS CONFIRMED THAT THE ERI TIMESTAMP WAS TRIPPED BY CHARGE TIME, RATHER THAN BATTERY VOLTAGE. LABORATORY TESTING ALSO REVEALED THAT THE BATTERY CELL IN THIS DEVICE HAD SUFFICIENT CAPACITY REMAINING, BUT HAD AN EXCESSIVE BUILD-UP OF INTERNAL IMPEDANCE THAT WAS HIGHER THAN ALLOWED FOR BY DESIGN. THIS RESULTED IN THE DEVICE'S INABILITY TO UTILIZE ALL AVAILABLE BATTERY CAPACITY.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) WAS ALLEGED TO DEPLETE PREMATURELY. THIS DEVICE WAS EXPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VENTAK PRIZM IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND 1852

Patients

Seq Age Sex Outcome Treatment
1